Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

RMJ. 2004; 29(2): 82-85

Treatment of chronic hepatitis B

Nasir Khokhar.

Chronic hepatitis B is a serious clinical problem with worldwide distribution and has been well documented in Pakistan (1,2). Chronic hepatitis B is important in Asia pacific region because of its perinatal mode of transmission and high prevalence rate in early childhood where the carriage of hepatitis B virus (HBV) ranges from 0.1-20% (1-3). Chronic hepatitis B virus infection generally consist of an early replicative phase which is characterized by presence of hepatitis Be antigen (HBeAg) and high levels of serum HBV DNA and alanine aminotransferase (ALT) may be normal or abnormal (3). A late phase involves immune clearance of HBV and destruction of infected hepatocytes which may be manifested by more marked increases of aminotransferase levels and spontaneous, as well as treatment related, HBeAg sero-conversion is common (3).

Key words: CHB, HBV Lamivudine

Similar Articles

Influence of Metabolic Syndrome on Cancer Risk in HBV Carriers: A Nationwide Population Based Study Using the National Health Insurance Service Database.
Choe JW, Hyun JJ, Kim B, Han KD
Journal of clinical medicine. 2021; 10(11):

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma.
Pezzuto F, Izzo F, De Luca P, Biffali E, Buonaguro L, Tatangelo F, Buonaguro FM, Tornesello ML
Cancers. 2021; 13(15):

Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years.
Zhang X, An X, Shi L, Yang X, Chen Y, Liu X, Li J, Ye F, Lin S
Scientific reports. 2021; 11(1): 13389

Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro.
Guo L, Gao S, Sun W, Wang Y, Zhao J
Clinics and research in hepatology and gastroenterology. 2021; (): 101813

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C,
The Journal of antimicrobial chemotherapy. 2021; ():

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites